Anterogen.Co.,Ltd. (KOSDAQ:065660)
37,100
+900 (2.49%)
At close: Dec 5, 2025
Anterogen.Co.,Ltd. Market Cap
Anterogen.Co.,Ltd. has a market cap or net worth of 371.23 billion as of December 5, 2025. Its market cap has increased by 149.33% in one year.
Market Cap
371.23B
Enterprise Value
327.14B
Revenue
7.32B
Ranking
n/a
PE Ratio
n/a
Stock Price
37,100.00
Market Cap Chart
Since February 15, 2016, Anterogen.Co.,Ltd.'s market cap has increased from 291.82B to 371.23B, an increase of 27.21%. That is a compound annual growth rate of 2.48%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.57T |
| Celltrion | 40.11T |
| ALTEOGEN | 27.92T |
| ABL Bio | 11.08T |
| SK Biopharmaceuticals | 10.61T |
| Yuhan | 8,911.91B |
| LigaChem Biosciences | 6,906.05B |
| Peptron | 6,668.76B |